Pioglitazone Tablets 15 mg (Pioglitazone Hydrochloride)

Adult dosage

This drug is taken orally once a day regardless of meals. 1. Monotherapy: Start with 15 mg once daily; if insufficient effect, the dose can be increased to 30 mg once daily. 2. Combination therapy: - When used with sulfonylureas, the initial dose is 15 mg once daily, and if hypoglycemia occurs, the sulfonylurea dose should be reduced. - When used with metformin, the initial dose is 15 mg once daily. - Insulin

Children's dosage

There is no experience using this drug in children under 18 years of age, so its use is not recommended.

This drug is used to treat type 2 diabetes and assists in the action of insulin. However, taking this drug can increase the risk of heart failure, particularly congestive heart failure, so it should not be used in patients with heart failure. During the use of this drug, symptoms of heart failure such as weight changes, shortness of breath, and swelling should be closely monitored, and if these symptoms appear, medical personnel should be notified immediately. Also, this drug can cause fluid retention and swelling, so it should be used with caution in patients with edema. This drug should not be administered to patients with a history of bladder cancer or active bladder cancer, and if symptoms such as blood in urine or urinary difficulties occur, the doctor should be notified immediately. Patients with impaired liver function or severe kidney dysfunction should also avoid taking this drug. Women who are pregnant or may become pregnant should not take this drug, and premenopausal women should use appropriate contraception as the risk of pregnancy may increase while taking this drug. This drug has a risk of hypoglycemia, so when taken with insulin or other hypoglycemic agents, hypoglycemia symptoms should be monitored, and adjustments to other medications may be necessary. Regular monitoring of blood sugar and liver function tests should be carried out during treatment, and if there are abnormal symptoms such as weight gain, edema, or shortness of breath, immediate consultation with medical personnel should be performed. Elderly patients or patients with impaired kidney function should be given this drug with greater caution, and in cases of overdose, appropriate treatment should be administered according to the symptoms. Finally, this drug has not established safety and efficacy in children, so it is advisable not to use it.

Serious side effects

Congestive heart failure, symptoms and signs of heart failure (including excessive and rapid weight changes, shortness of breath, edema), visible hematuria, urinary difficulties, urgency, severe edema, severe allergic reactions (urticaria, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor), severe skin reactions (severe rash with high fever, blisters, skin peeling, pain in oral/eye mucosa), respiratory problems (shortness of breath or difficulty breathing,

Mild side effects

• Upper respiratory tract infection
• headache
• sinusitis
• myalgia
• pharyngitis
• abdominal distension
• weight gain
• urinary tract infection
• diarrhea
• lumbago

This drug should be stored in a container that does not allow light and air to enter, and in a place that is not humid. The appropriate storage temperature is between 15 and 30 degrees Celsius, and maintaining a temperature around 25 degrees is preferred.

Appearance

This drug is a white, round tablet.

Package unit

30 tablets/bottle, 100 tablets/bottle